The Defect in the Hunter Syndrome: Deficiency of Sulfoiduronate Sulfatase

AUTOR(ES)

Bach, Gideon

RESUMO

Skin fibroblasts cultured from patients affected with the Hunter syndrome are deficient in the activity of a protein, named the “Hunter corrective factor,” that is required for degradation of dermatan and heparan sulfates. We now show that this factor, purified from human urine, removes about 2% of the sulfate residues from [35S]mucopolysaccharide accumulated within Hunter fibroblasts; these groups are derived from “oversulfated” regions of the polymer. Acetone-powder extracts of fibroblasts derived from patients with the Hunter syndrome are deficient in this sulfatase, in contrast to similar extracts from fibroblasts of individuals of other genotype. Hunter corrective factor coupled to α-L-iduronidase (or alternatively, mixed extracts from Hurler and Hunter fibroblasts) release iduronic acid from 4-O-α-L-sulfoiduronosyl-D-sulfoanhydromannose. We conclude that the Hunter corrective factor is a sulfatase for sulfated iduronic acid residues.

Documentos Relacionados

• Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.
• Disc oedema in association with Hunter's syndrome: ocular histopathological findings.
• THE DEFECT IN HURLER AND HUNTER SYNDROMES, II. DEFICIENCY OF SPECIFIC FACTORS INVOLVED IN MUCOPOLYSACCHARIDE DEGRADATION
• Conotruncal heart defect/microphthalmia syndrome: delineation of an autosomal recessive syndrome.
• Intrinsic defect of the immune system in children with Down syndrome: a review